A nomogram for predicting recurrence-free survival in patients with high-risk GIST receiving adjuvant imatinib: A nationwide registry study.

Saved in:
Bibliographic Details
Title: A nomogram for predicting recurrence-free survival in patients with high-risk GIST receiving adjuvant imatinib: A nationwide registry study.
Authors: Yeh CN; Division of General Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan 333, Taiwan, R.O.C.; Institute of Stem Cell and Translational Cancer Research, Chang Gung Memorial Hospital at Linkou, Chang Gung University, Taoyuan 333, Taiwan, R.O.C.; School of Medicine, National Tsing Hua University, Hsinchu 300, Taiwan, R.O.C., Shan YS; Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan, R.O.C., Yang CY; Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 100, Taiwan, R.O.C., Hsiao CF; Institute of Population Health Sciences, National Health Research Institutes, Zhunan 350, Taiwan, R.O.C., Tsai CH; Department of Surgery, MacKay Memorial Hospital and Mackay Medical College, Taipei 104, Taiwan, R.O.C., Wang CC; Department of Internal Medicine, Changhua Christian Hospital, Changhua city, Chuanghua County 500, Taiwan, R.O.C., Lin MT; Department of Surgery, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei 100, Taiwan, R.O.C., Ting CF; Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan, R.O.C., Chan DC; Division of General Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan, R.O.C., Chen TH; Department of Surgery, China Medical University Hospital, China Medical University, Taichung 404, Taiwan, R.O.C., Yen CC; Division of Medical Oncology, Center for Immuno-oncology, Department of Oncology, Taipei Veterans General Hospital, Taipei 112, Taiwan, R.O.C.; Division of Clinical Research, Department of Medical Research, Taipei Veterans General Hospital, Taipei 112, Taiwan, R.O.C.; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei 112, Taiwan, R.O.C.; Institute of Biopharmaceutical Sciences, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei 112, Taiwan, R.O.C., Chen YY; Department of Medical Oncology; Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung 833, Taiwan, R.O.C., Lin HY; Department of Internal Medicine, Changhua Christian Hospital, Changhua city, Chuanghua County 500, Taiwan, R.O.C., Yeh TS; Division of General Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan 333, Taiwan, R.O.C., Ho CL; Division of Hematology and Oncology, Department of Internal Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei 114, Taiwan, R.O.C.; Division of Hematology and Oncology, Medical Department, Taipei Tzu Chi Hospital, Taipei 231, Taiwan, R.O.C., Shieh TY; Division of Gastroenterology, Department of Internal Medicine, Mackay Memorial Hospital, Taipei 104, Taiwan, R.O.C., Bai LY; Department of Internal Medicine, China Medical University Hospital, Taichung 404, Taiwan, R.O.C., Hsu JT; Division of General Surgery, Department of Surgery, Chang Gung Memorial Hospital, Linkou, Chang Gung University, Taoyuan 333, Taiwan, R.O.C., Chen IS; Division of General Surgery, Department of Surgery, Kaohsiung Veterans General Hospital and National Yang-Ming University, Kaohsiung 813, Taiwan, R.O.C., Chen LT; Center for Cancer Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan, R.O.C.; National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan, R.O.C.; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan, R.O.C.; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan, R.O.C., Tsai HJ; National Institute of Cancer Research, National Health Research Institutes, Tainan 704, Taiwan, R.O.C.; Department of Oncology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan, R.O.C.; Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 807, Taiwan, R.O.C.
Corporate Authors: Taiwan Cooperative Oncology Group Gist Study Group
Source: Experimental and therapeutic medicine [Exp Ther Med] 2026 Mar 24; Vol. 31 (5), pp. 145. Date of Electronic Publication: 2026 Mar 24 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Spandidos Pub.] Country of Publication: Greece NLM ID: 101531947 Publication Model: eCollection Cited Medium: Internet ISSN: 1792-1015 (Electronic) Linking ISSN: 17920981 NLM ISO Abbreviation: Exp Ther Med Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1792-1015
DOI:10.3892/etm.2026.13140